Serum Neurofilament Light Chain Levels in Leprosy Patients: A Cross‐Sectional Study
Tropical Medicine & International Health · 2026
DOI: 10.1111/tmi.70161 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Tropical Medicine & International Health, 2026. Verfasst von Ananta Khurana und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, Delhi, Ind…. Hauptthemen laut MEDLINE: Neurofilament Proteins, Leprosy, Peripheral Nervous System Diseases. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Indian Association of Dermatology, Venereology and Leprosy (IADVL) Academy.
Abstract (Originalsprache)
Background
Leprosy causes nerve damage which may be clinical or subclinical. Leprosy‐associated peripheral neuropathy (LPN) has an unpredictable course despite treatment with multi drug therapy, and results in significant disabilities and stigma. There are no reliable biomarkers to quantify nerve damage in leprosy or predict impending clinical neuropathy.
Methods
We conducted a cross‐sectional observational study over 1 year. Leprosy patients with peripheral neuropathy (LPN, n = 30), leprosy patients without detectable peripheral neuropathy (L, n = 20) and healthy controls (HC, n = 20) were included. Patients with other known causes of peripheral neuropathy were excluded. The primary outcome was to estimate serum neurofilament light chain (NfL) levels using the Single Molecular Assay (SiMoA) HD‐X analyzer. NfL concentrations were compared across the three groups and correlated with disease spectrum, bacterial load and severity of nerve function impairment (NFI).
Results
The median NfL level in the LPN group was 12.1 pg/mL (range: −1.68 to 224), in the L group was 17.25 pg/mL (range: 4.43–53.8) and in HCs was 4.85 pg/mL (range: 0.252–23.7). Leprosy patients had significantly higher NfL levels than healthy controls ( p = 0.008), with a cut‐off value of 7.48 pg/mL using ROC analysis (sensitivity 76%; specificity 25%). NfL levels between the LPN and L groups were comparable ( p = 0.56). No significant correlation was found between NfL levels and severity of clinical neuropathy, although a non‐significant positive trend with the bacterial index was noted.
Conclusions
Serum NfL levels were significantly higher in leprosy patients compared to healthy controls, suggesting prominent axonal damage. NfL may serve as a minimally invasive biomarker of nerve damage in leprosy, but further longitudinal studies are needed to validate its predictive and therapeutic utility in LPN. Trial Registration: CTRI/2024/04/081960
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, Delhi, India.
- Department of Neurochemistry, National Institute of Mental Health & Neuro Sciences, Bengaluru, India.
- Department of Community Medicine, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, Delhi, India.
ORCID-Profile: Ananta Khurana, Savitha Sharath, Sarada Subramanian, Kabir Sardana
Förderung
- Indian Association of Dermatology, Venereology and Leprosy (IADVL) Academy
Zitieren
APA
Khurana, A., Sharath, S., Subramanian, S., Gupta, S., Sardana, K., Chaudhary, R., & Panesar, S. (2026). Serum Neurofilament Light Chain Levels in Leprosy Patients: A Cross‐Sectional Study. Tropical Medicine & International Health. https://doi.org/10.1111/tmi.70161
Vancouver
Khurana A, Sharath S, Subramanian S, Gupta S, Sardana K, Chaudhary R, et al. Serum Neurofilament Light Chain Levels in Leprosy Patients: A Cross‐Sectional Study. Tropical Medicine & International Health. 2026. doi:10.1111/tmi.70161
BibTeX
@article{Khurana2026,
author = {Khurana, Ananta and Sharath, Savitha and Subramanian, Sarada and Gupta, Saurabh and Sardana, Kabir and Chaudhary, Ritul and Panesar, Sanjeet},
title = {Serum Neurofilament Light Chain Levels in Leprosy Patients: A Cross‐Sectional Study},
journal = {Tropical Medicine & International Health},
year = {2026},
doi = {10.1111/tmi.70161}
}
EUVIMED